Aptevo Therapeutics Inc
APVO
|
|
| |
|
| Trading Volume | 1,151,051 |
|
|
0.44 - 0.13 |
| Market Cap Full | $ 2.3M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | -28.7% | -12.1% | -25.4% |
| Q2 | - | - | -28.4% | -39% |
| Q3 | - | - | -77.4% | -15.1% |
| Q4 | - | - | -46.9% | -23.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -9.9 | 4.3 | -24.1 | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -0.9 | -7.8 | -3.8 | -5.9 | -18.8 | -6.4 | -28.8 | -57.7 | -25 | -14.2 | -33.9 | -3.2 |
| 2022 | |||||||||||
| -26.3 | -0.7 | 1.9 | -26.8 | 6.5 | -21.8 | 10.1 | -10.2 | -14.1 | -0.7 | 3.3 | -25.6 |
| 2021 | |||||||||||
| -8.6 | -2.4 | -6.7 | -11.7 | -3 | -14.2 | -16.3 | -4.4 | -14 | -1.3 | -35 | -20.5 |
| 2020 | |||||||||||
| -0.2 | -28.6 | 735.2 | 35.1 | 14 | 46.5 | 0.6 | -6.7 | -1 | -16.5 | 574.9 | -16.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.4 | -1.6 | -1.6 | 0.9 |
| Q2 | -1.2 | 5.6 | -1.8 | -2.1 |
| Q3 | -0.5 | -1.5 | -1.4 | -2.1 |
| Q4 | 0 | -1 | -1.3 | -1.9 |
| A | -1.34 | 1.6 | -6.1 | -5.2 |